You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

METROMIDOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Metromidol patents expire, and what generic alternatives are available?

Metromidol is a drug marketed by Labs Af and is included in one NDA.

The generic ingredient in METROMIDOL is metronidazole. There are eighteen drug master file entries for this compound. Seventy-two suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Metromidol

A generic version of METROMIDOL was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METROMIDOL?
  • What are the global sales for METROMIDOL?
  • What is Average Wholesale Price for METROMIDOL?
Summary for METROMIDOL
Drug patent expirations by year for METROMIDOL

US Patents and Regulatory Information for METROMIDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Labs Af METROMIDOL metronidazole TABLET;ORAL 074523-001 Oct 24, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Labs Af METROMIDOL metronidazole TABLET;ORAL 074523-002 Oct 24, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.